or Try an Advanced Search...

    Technical Analysis for WINT - Windtree Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.51 -0.51% 0.00
    WINT closed up 9.13 percent on Wednesday, November 20, 2024, on 48 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical WINT trend table...
    Date Alert Name Type % Chg
    1,2,3 Retracement Bearish Bearish Swing Setup -0.51%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.51%
    Pocket Pivot Bullish Swing Setup -0.51%
    Narrow Range Bar Range Contraction -0.51%
    Outside Day Range Expansion -0.51%
    Wide Bands Range Expansion -0.51%
    Oversold Stochastic Weakness -0.51%
    New 52 Week Closing Low Bearish 8.57%
    Narrow Range Bar Range Contraction 8.57%
    Outside Day Range Expansion 8.57%
    Older End-of-Day Signals for WINT ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 2 hours ago
    Down 3% about 2 hours ago
    Down 2 % about 2 hours ago
    Down 1% about 2 hours ago
    Up 1% about 2 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    WINT Chart by TradingView
    Basic chart:

    Profile

    Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Respiratory Diseases Syndromes Surfactant Neonatology Respiratory Distress Respiratory Distress Syndrome

    Is WINT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Windtree Therapeutics appoints new CEO
    Nov 14 Windtree Announces Leadership Transition Plan With Industry Veterans
    Nov 13 WINT: Patient Enrollment in SEISMiC C Trial Starts, Patent Position Expands
    Nov 4 Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Hong Kong
    Oct 30 Windtree Therapeutics Initiates SEISMiC C Study of Istaroxime in SCAI Stage C Cardiogenic Shock for Planned Completion of Phase 2b and Transition to Phase 3
    Oct 24 Windtree Therapeutics completes national phase filings for istaroxime
    Oct 23 Windtree Announces Istaroxime Cardiogenic Shock Patent Filings In Countries Around the World
    Oct 21 Windtree To Present at the ThinkEquity Conference on October 30th
    Oct 17 Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Japan
    Oct 14 WINT: Lead Drug Candidates, Multiple Programs, Several Upcoming Expected Milestones
    See more WINT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.3074
    52 Week Low 0.4515
    Average Volume 1,800,313
    200-Day Moving Average 4.74
    50-Day Moving Average 1.38
    20-Day Moving Average 0.64
    10-Day Moving Average 0.53
    Average True Range 0.12
    RSI (14) 28.06
    ADX 37.65
    +DI 14.68
    -DI 35.30
    Chandelier Exit (Long, 3 ATRs) 0.70
    Chandelier Exit (Short, 3 ATRs) 0.82
    Upper Bollinger Bands 0.91
    Lower Bollinger Band 0.38
    Percent B (%b) 0.25
    BandWidth 81.78
    MACD Line -0.30
    MACD Signal Line -0.38
    MACD Histogram 0.0746
    Fundamentals Value
    Market Cap 3.78 Million
    Num Shares 7.41 Million
    EPS -16.79
    Price-to-Earnings (P/E) Ratio -0.03
    Price-to-Sales 660.53
    Price-to-Book 0.36
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.60
    Resistance 3 (R3) 0.59 0.55 0.58
    Resistance 2 (R2) 0.55 0.53 0.56 0.58
    Resistance 1 (R1) 0.53 0.52 0.54 0.54 0.57
    Pivot Point 0.50 0.50 0.50 0.50 0.50
    Support 1 (S1) 0.47 0.47 0.49 0.48 0.45
    Support 2 (S2) 0.44 0.46 0.44 0.44
    Support 3 (S3) 0.42 0.44 0.44
    Support 4 (S4) 0.42